Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 121 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 20,895.0 | $262K | 0.02% | -451.0 | -2.1% | $12.52 | +21.7% |
| 122 | FTRE | FORTREA HOLDINGS INC | Healthcare | 15,057.0 | $260K | 0.02% | -859.0 | -5.4% | $17.25 | +18.4% |
| 123 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 9,502.0 | $259K | 0.02% | -682.0 | -6.7% | $27.22 | +28.5% |
| 124 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 44,635.0 | $245K | 0.02% | -3K | -6.7% | $5.50 | -6.2% |
| 125 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 28,243.0 | $239K | 0.02% | -2K | -6.5% | $8.46 | +128.7% |
| 126 | COLL | COLLEGIUM PHARMACEUTICAL INC | Healthcare | 5,151.0 | $238K | 0.02% | -371.0 | -6.7% | $46.30 | -50.8% |
| 127 | NVCR | NOVOCURE LTD | Healthcare | 18,247.0 | $236K | 0.02% | -1K | -6.9% | $12.93 | +28.9% |
| 128 | ARDX | ARDELYX INC | Healthcare | 39,593.0 | $231K | 0.02% | -3K | -6.3% | $5.83 | -37.9% |
| 129 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 8,697.0 | $229K | 0.02% | -645.0 | -6.9% | $26.29 | -2.7% |
| 130 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 27,037.0 | $212K | 0.02% | -1K | -4.5% | $7.85 | +11.2% |
| 131 | AMPH | AMPHASTAR PHARMACEUTICALS IN | Healthcare | 7,488.0 | $201K | 0.01% | -662.0 | -8.1% | $26.78 | -9.2% |
| 132 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 11,592.0 | $192K | 0.01% | -843.0 | -6.8% | $16.59 | -53.2% |
| 133 | SPRY | ARS PHARMACEUTICALS INC | Healthcare | 16,107.0 | $188K | 0.01% | -1K | -7.0% | $11.65 | -61.5% |
| 134 | — | INHIBRX BIOSCIENCES INC | — | 2,370.0 | $187K | 0.01% | -169.0 | -6.7% | $79.00 | — |
| 135 | GRFS | GRIFOLS SA-ADR | Healthcare | 19,879.0 | $186K | 0.01% | -2K | -7.0% | $9.35 | -20.4% |
| 136 | CSTL | CASTLE BIOSCIENCES INC | Healthcare | 4,756.0 | $185K | 0.01% | -329.0 | -6.5% | $38.90 | -10.4% |
| 137 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 7,010.0 | $181K | 0.01% | -866.0 | -11.0% | $25.88 | -4.6% |
| 138 | URGN | UROGEN PHARMA LTD | Healthcare | 7,627.0 | $179K | 0.01% | -482.0 | -5.9% | $23.42 | +82.6% |
| 139 | XNCR | XENCOR INC | Healthcare | 11,636.0 | $178K | 0.01% | -866.0 | -6.9% | $15.31 | +64.3% |
| 140 | NVAX | NOVAVAX INC | Healthcare | 26,479.0 | $178K | 0.01% | -2K | -7.0% | $6.72 | +61.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
40.3%
Healthcare
21.6%
Communication Services
10.8%
Financial Services
10.7%
Consumer Cyclical
10.3%
Consumer Defensive
2.8%
Industrials
2.0%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%